Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Drugs Targeting B-Cells in Autoimmune Diseases

Buch | Hardcover
XI, 292 Seiten
2013 | 2014
Springer Basel (Verlag)
978-3-0348-0705-0 (ISBN)

Lese- und Medienproben

Drugs Targeting B-Cells in Autoimmune Diseases -
CHF 224,65 inkl. MwSt
  • Versand in 10-14 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This book offers a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia.
This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.

Historic outline of the development of drugs targeting B-cells.- Understanding B-cell biology.- Pharmacological effects and mechanisms of action of agents blocking B cells.- Systemic lupus erythematosus: direct B-cell blocking.- Systemic lupus erythematosus: indirect B-cell blocking.- B-cell targeted therapies in rheumatoid arthritis.- B-cell targeted therapies in Primary Sjögren Syndrome.- Targeting B cells in ANCA-associated vasculitis.- B-cell targeted therapies in systemic sclerosis and inflammatory myopathies.- B-cell targeted therapies in cryoglobulinemia.- B-cell targeted therapies in autoimmune cytopenias and thrombosis.- Targeting B cells in neurological autoimmune diseases.- Targeting B cells in other systemic autoimmune diseases.- Safety of B-cell targeted therapies.- The future potential of biosimilars targeting B-cells.

Erscheint lt. Verlag 9.12.2013
Reihe/Serie Milestones in Drug Therapy
Zusatzinfo XI, 292 p. 3 illus., 2 illus. in color.
Verlagsort Basel
Sprache englisch
Maße 155 x 235 mm
Gewicht 619 g
Themenwelt Medizinische Fachgebiete Innere Medizin Rheumatologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Studium Querschnittsbereiche Infektiologie / Immunologie
Schlagworte Cryoglobulinemia • Inflammatory myopathies • Rheumatoid Arthritis • Sjögren syndrome • Systemic Lupus Erythematosus • systemic sclerosis • thrombosis • vasculitis
ISBN-10 3-0348-0705-8 / 3034807058
ISBN-13 978-3-0348-0705-0 / 9783034807050
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Alexander Pfeil; Peter Oelzner; Joachim Böttcher

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 61,60
Information für Erkrankte, Angehörige und Betreuende

von Matthias Schneider

Buch | Softcover (2023)
Springer (Verlag)
CHF 32,15